134 related articles for article (PubMed ID: 19557803)
1. Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy.
Larsen SB; Omkvist DH; Brodin B; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS
ChemMedChem; 2009 Sep; 4(9):1439-45. PubMed ID: 19557803
[TBL] [Abstract][Full Text] [Related]
2. QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
Larsen SB; Jørgensen FS; Olsen L
J Chem Inf Model; 2008 Jan; 48(1):233-41. PubMed ID: 18092768
[TBL] [Abstract][Full Text] [Related]
3. Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs.
Våbenø J; Nielsen CU; Steffansen B; Lejon T; Sylte I; Jørgensen FS; Luthman K
Bioorg Med Chem; 2005 Mar; 13(6):1977-88. PubMed ID: 15727852
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
[TBL] [Abstract][Full Text] [Related]
5. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
[TBL] [Abstract][Full Text] [Related]
8. In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.
Ekins S; Johnston JS; Bahadduri P; D'Souza VM; Ray A; Chang C; Swaan PW
Pharm Res; 2005 Apr; 22(4):512-7. PubMed ID: 15846457
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
10. Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.
Våbenø J; Lejon T; Nielsen CU; Steffansen B; Chen W; Ouyang H; Borchardt RT; Luthman K
J Med Chem; 2004 Feb; 47(4):1060-9. PubMed ID: 14761208
[TBL] [Abstract][Full Text] [Related]
11. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
[TBL] [Abstract][Full Text] [Related]
12. Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.
Andersen R; Jørgensen FS; Olsen L; Våbenø J; Thorn K; Nielsen CU; Steffansen B
Pharm Res; 2006 Mar; 23(3):483-92. PubMed ID: 16489544
[TBL] [Abstract][Full Text] [Related]
13. A virtual screening study of the 18 kDa translocator protein using pharmacophore models combined with 3D-QSAR studies.
Tuccinardi T; Taliani S; Bellandi M; Da Settimo F; Da Pozzo E; Martini C; Martinelli A
ChemMedChem; 2009 Oct; 4(10):1686-94. PubMed ID: 19688807
[TBL] [Abstract][Full Text] [Related]
14. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Laggner C; Schieferer C; Fiechtner B; Poles G; Hoffmann RD; Glossmann H; Langer T; Moebius FF
J Med Chem; 2005 Jul; 48(15):4754-64. PubMed ID: 16033255
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin.
Thorsteinson N; Ban F; Santos-Filho O; Tabaei SM; Miguel-Queralt S; Underhill C; Cherkasov A; Hammond GL
Toxicol Appl Pharmacol; 2009 Jan; 234(1):47-57. PubMed ID: 18725242
[TBL] [Abstract][Full Text] [Related]
17. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
18. Structure-based model profiles affinity constant of drugs with hPEPT1 for rapid virtual screening of hPEPT1's substrate.
Sun L; Meng S
SAR QSAR Environ Res; 2016 Aug; 27(8):637-52. PubMed ID: 27586363
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
Macdougall IJ; Griffith R
J Mol Graph Model; 2008 Apr; 26(7):1113-24. PubMed ID: 18023378
[TBL] [Abstract][Full Text] [Related]
20. Discovery of α7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13.
Blum LC; van Deursen R; Bertrand S; Mayer M; Bürgi JJ; Bertrand D; Reymond JL
J Chem Inf Model; 2011 Dec; 51(12):3105-12. PubMed ID: 22077916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
